LENTARON Liquide

Country: Կանադա

language: ֆրանսերեն

source: Health Canada

active_ingredient:

Formestane; Chlorure de sodium

MAH:

NOVARTIS PHARMACEUTICALS CANADA INC

ATC_code:

L02BG02

INN:

FORMESTANE

dosage:

250MG; .9%

pharmaceutical_form:

Liquide

composition:

Formestane 250MG; Chlorure de sodium .9%

administration_route:

Intramusculaire

units_in_package:

1 X 250MG + 1X0.9%G

prescription_type:

Prescription

therapeutic_area:

ANTINEOPLASTIC AGENTS

leaflet_short:

Numéro de groupe d'ingrédients actifs (GIA) :0226698001; AHFS:

authorization_status:

ANNULÉ APRÈS COMMERCIALISATION

authorization_date:

1999-08-04